SEOUL, April 16 (Korea Bizwire) — South Korean biotech company Huons Global said Friday that it has signed a technology transfer deal with Russia’s sovereign wealth fund to produce a Russian COVID-19 vaccine in South Korea. Under the agreement with the Russian Direct Investment Fund, the Huons Global-led consortium will manufacture Sputnik V in South [...]
SEOUL, April 15 (Korea Bizwire) — South Korean bio-tech company Isu Abxis said Thursday that a technology transfer deal with Russia’s sovereign wealth fund will pave the way for it to produce Sputnik V COVID-19 vaccine soon. Under the agreement with Russia’s sovereign wealth fund, Russian Direct Investment Fund (RDIF), and local bio firm GL [...]
SEOUL, Nov. 13 (Korea Bizwire) — South Korean bio company GL Rapha will produce over 150 million annual doses of Russia’s COVID-19 vaccine for global distribution, Russia’s sovereign wealth fund said Friday. The Russian Direct Investment Fund (RDIF) said GL Rapha will begin manufacturing Sputnik V in South Korea next month, which it described “the [...]